Clonazolam 0.6 mg Pellets – Precision Dosed Research Chemical Compound

Introduction to Clonazolam

Clonazolam is a highly potent benzodiazepine analog of the triazolobenzodiazepine class. These 0.6 mg pellets were developed for controlled scientific research into the pharmacological properties of GABA-A receptor modulators. O-DSMT 50 mg Pellets

Caractéristiques du produit

• Exact dosage : 0.6 mg per pellet
• Uniform composition : For consistent research results
• Stable matrix formulation : Increased structural integrity
• Batch validation : Each production batch subjected to analytical control

Propriétés pharmacologiques

• GABA-A receptor activity : Strong allosteric modulation
• Durée d'action : 6–12 hours (preclinical)
• Anxiolytic, sedative and muscle relaxant profile
• Metabolic half-life : Including active metabolites

Applications de recherche

1. GABAergic transmission study
2. Preclinical behavioral models (anxiety, sedation)
3. Potency and structure comparison within benzodiazepines

Spécifications techniques

• Shape: round pellets
• Diameter: 2.5mm ± 0.1mm
• Poids : 10 mg ± 0,5 mg
• Color: white to light cream. buvards 1V-LSD 150 MCG

Dosage Guidelines for Research

For scientific reference:

• In vitro : 0.1–1.0 μM
• In vivo preclinical : 0.01–0.1 mg/kg
• Behavioural studies : 0.05–0.3 mg/kg

Protocoles de sécurité

• Storage: dry and dark at 15–25°C
• Light and moisture sensitive: protectively packaged
• Compatible with common buffers

Documentation à la livraison

• Analytical certificate
• Specification file
• Fiche de données de sécurité (FDS)
• Données de stabilité

For research purposes only by qualified professionals. Not for consumption or medical use. Graines d'iboga